LEADER 04550nam 2201153z- 450 001 9910557343003321 005 20240612160332.0 035 $a(CKB)5400000000042461 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/77136 035 $a(EXLCZ)995400000000042461 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBioactive Molecules from Extreme Environments II 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (336 p.) 311 $a3-0365-2718-4 311 $a3-0365-2719-2 330 $aThis Special Issue, as a continuation of the previous Special Issue, ?Bioactive Molecules from Extreme Environments? (https://www.mdpi.com/journal/marinedrugs/special_issues/Extreme_Environments accessed on 4 November 2021), includes 10 research articles and 2 reviews, providing a wide overview of the chemical biodiversity offered by different marine organisms inhabiting extreme environments to be used for biotechnological and pharmaceutical applications. The six articles in this Special Issue are focused on the polar regions, which represent an untapped source of marine natural products and are still largely unexplored compared to more accessible sites. Many of these articles refer to Antarctica, which is the coldest and most inaccessible continent on the Earth, where extreme temperatures, light and ice have selected biological communities with a unique suite of bioactive metabolites. The marine organisms of Arctic and Antarctic environments are a reservoir of natural compounds, exhibiting huge structural diversity and significant bioactivities that could be used in human applications. 606 $aResearch & information: general$2bicssc 606 $aChemistry$2bicssc 610 $aArctic/Antarctic 610 $amarine bioprospecting 610 $amarine natural product 610 $aterpene 610 $aterpenoid 610 $abiotechnological application 610 $adrug discovery 610 $amicroalgae 610 $aMuriellopsis 610 $aspray drying 610 $afreeze-drying 610 $alutein 610 $asupercritical fluid extraction 610 $acyclic tripeptides 610 $aantibacterial 610 $aAntarctica sponge-derived fungus 610 $aAspergillus insulicola 610 $apsychrophiles 610 $aAntarctic bacteria 610 $aLipopolysaccharide (LPS) 610 $alipid A 610 $astructural characterization 610 $aMALDI-TOF mass spectrometry 610 $amarine natural products 610 $aMollusca 610 $aGastropoda 610 $achemical ecology 610 $acrustin 610 $aantimicrobial peptides 610 $ashrimp 610 $adeep-sea hydrothermal vent 610 $adeep-sea microorganism 610 $afungus 610 $aPenicillium griseofulvum 610 $aanti-food allergy 610 $afungal metabolites 610 $aPaenibacillus 610 $aArctic 610 $aSvalbard 610 $aMarfey?s method 610 $aDP4 calculation 610 $aquinone reductase 610 $alipopeptide 610 $a3-amino-2-pyrrolidinone 610 $agreen synthesis 610 $abiomaterials 610 $ametal 610 $aantibiotics 610 $ananotechnology 610 $adeep sea natural products 610 $aMariana Trench 610 $aDermacoccus abyssi MT 1.1T 610 $a13C-NMR chemical shift linear and multiple regression 610 $a(DFT)-UV-Vis spectral calculation 610 $aphenoxazine 610 $adermacozine 610 $aabsorption maxima in the near infrared region 610 $aAntarctica 610 $asponges 610 $amycalols 610 $amarine biotechnology 610 $aantifungal activity 610 $aBacillus amyloliquefaciens 610 $aPanama disease 610 $aFusarium oxysporum f. sp. cubense 610 $abioactive compound 610 $aiturin A5 615 7$aResearch & information: general 615 7$aChemistry 700 $aGiordano$b Daniela$c(Researcher)$4edt$078443 702 $aGiordano$b Daniela$c(Researcher)$4oth 906 $aBOOK 912 $a9910557343003321 996 $aBioactive Molecules from Extreme Environments II$93036784 997 $aUNINA